These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35344242)

  • 21. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
    Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
    J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles.
    Li X; Aldayel AM; Cui Z
    J Control Release; 2014 Jan; 173():148-57. PubMed ID: 24188959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant.
    Levesque PM; Foster K; de Alwis U
    Hum Vaccin; 2006; 2(2):74-7. PubMed ID: 17012880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
    Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
    Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.
    Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF
    Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel identified aluminum hydroxide-induced pathways prove monocyte activation and pro-inflammatory preparedness.
    Kooijman S; Brummelman J; van Els CACM; Marino F; Heck AJR; Mommen GPM; Metz B; Kersten GFA; Pennings JLA; Meiring HD
    J Proteomics; 2018 Mar; 175():144-155. PubMed ID: 29317357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suramin has adjuvant properties and promotes expansion of antigen-specific Th1 and Th2 cells in vivo.
    Denkinger M; Shive CL; Pantenburg B; Forsthuber TG
    Int Immunopharmacol; 2004 Jan; 4(1):15-24. PubMed ID: 14975356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
    Richards RL; Alving CR; Wassef NM
    J Pharm Sci; 1996 Dec; 85(12):1286-9. PubMed ID: 8961140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preclinical studies of an adsorbed diphtheria-tetanus-pertussis vaccine (ADTP-vaccine) with acellular pertussis component].
    Zaĭtsev EM; Britsina MV; Bazhanova IG; Mertsalova NU; Ozeretskovskaia MN; Ermolova EV; Plekhanova NG; Mikhaĭlova NA; Kolyshkin VA; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):44-9. PubMed ID: 24605674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of stimulation of the immune response by aluminum adjuvants.
    HogenEsch H
    Vaccine; 2002 May; 20 Suppl 3():S34-9. PubMed ID: 12184362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
    Sokolovska A; Hem SL; HogenEsch H
    Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity.
    Li X; Hufnagel S; Xu H; Valdes SA; Thakkar SG; Cui Z; Celio H
    ACS Appl Mater Interfaces; 2017 Jul; 9(27):22893-22901. PubMed ID: 28621928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation.
    Colaprico A; Senesi S; Ferlicca F; Brunelli B; Ugozzoli M; Pallaoro M; O'Hagan DT
    Vaccine; 2020 Apr; 38(19):3600-3609. PubMed ID: 32063436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
    Hansen B; Belfast M; Soung G; Song L; Egan PM; Capen R; Hogenesch H; Mancinelli R; Hem SL
    Vaccine; 2009 Feb; 27(6):888-92. PubMed ID: 19071182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic understanding of the aspect ratio-dependent adjuvanticity of engineered aluminum oxyhydroxide nanorods in prophylactic vaccines.
    Liang Z; Wang X; Yu G; Li M; Shi S; Bao H; Chen C; Fu D; Ma W; Xue C; Sun B
    Nano Today; 2022 Apr; 43():101445. PubMed ID: 35261619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Reprogramming of Macrophages upon In Vitro Incubation with Aluminum-Based Adjuvant.
    Danielsson R; Ferey N; Mile I; Eriksson H
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses.
    Chen Z; Hao X; Wang H; Zhong X; Chen X; Zhao Y; Zhang Y; Du G; Sun X
    J Control Release; 2022 Sep; 349():699-711. PubMed ID: 35907590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro interactions between macrophages and aluminum-containing adjuvants.
    Rimaniol AC; Gras G; Clayette P
    Vaccine; 2007 Sep; 25(37-38):6784-92. PubMed ID: 17689842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances on the early cellular events occurring upon exposure of human macrophages to aluminum oxyhydroxide adjuvant.
    Masson JD; Badran G; Domdom MA; Gherardi RK; Mograbi B; Authier FJ; Crépeaux G
    Sci Rep; 2023 Feb; 13(1):3198. PubMed ID: 36823452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.